Dexcom is facing scrutiny and class-action lawsuits over alleged safety and accuracy issues with its G7 monitor.
Zacks Investment Research on MSN
Can Dexcom Deliver Strong Q3 Earnings on Stelo Gains and G7 Adoption?
DexCom, Inc. DXCM is scheduled to report third-quarter 2025 resultson Oct. 30, after the closing bell. In the last reported ...
Continuous glucose monitors — the tiny sensors once reserved for people with diabetes — are now appearing on the arms of ...
Artisan Partners, an investment management company, released its “Artisan Mid Cap Fund” third-quarter 2025 investor letter. A ...
Walmart will become the first U.S. retailer to sell Abbott’s continuous glucose monitoring device as the medtech giant looks to broaden its sales potential for its growing business unit. | Walmart ...
New York Magazine on MSN
What a Diabetes Diagnosis Taught Me About MAHA
People develop type 2 diabetes for a combination of reasons, like a sedentary lifestyle and an unhealthy diet, but genetics ...
Health Panels follows the lead of competitors by offering blood tests that users can schedule and review within the Oura app.
Experts weigh in on the most promising AI applications, from diabetic retinopathy screening to smarter insulin delivery, and ...
Oura Ring creator ŌURA has raised funding of more than $900m, earmarked for the growth of the company's health technology ...
Rising Diabetes, Tech Innovations, and Home Care Models Drive CGM Adoption. Saudi Arabian Self-monitoring Blood Glucose ...
Android Central on MSN
Google's Fitbit revamp is all about Gemini coaching; here's how it works
Fitbit is getting a major overhaul, its first since the 2023 Material You redesign, prioritizing a conversational AI that ...
One of our all-time favorite fitness trackers, the Oura ring, is currently at its lowest price ever. Nab the third-generation version of our favorite smart ring in select styles and colors for just ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback